Market Overview - The A-share market experienced a significant rally, with major indices rising across the board, particularly the ChiNext Index, which surpassed 3000 points for the first time in over three years [1][6] - The STAR 50 Index saw a remarkable increase, with intraday gains exceeding 5%, marking its largest intraday rise since September [2][6] Key Stocks Performance - Haiguang Information, a key stock in the STAR Market, hit the daily limit with a 20% increase, reaching a historical high of 220.84 yuan, resulting in a market capitalization exceeding 510 billion yuan [4][5] - Another significant stock, Cambrian Biologics-U, surged with intraday gains of over 10%, while SMIC also saw a rise of more than 8% [6] Sector Performance - In terms of sector performance, the telecommunications sector experienced a substantial increase, with intraday gains exceeding 6%, followed by the electronics sector with over 5%, and the computer sector with gains exceeding 3% [8] Hong Kong Market - The Hong Kong market showed mixed results, with the Hang Seng Index experiencing slight declines, although stocks like SMIC and New Oriental saw notable intraday gains [8] Clinical Trial Announcement - Yaojie Ankang-B announced a significant clinical trial for its core product, Tinengotinib, which has shown promising early results in treating HR+/HER2- breast cancer patients, potentially offering new treatment options [9][10]